Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Molecular Mechanisms and Clinical Evidence Supporting the Four Pillars of Therapy in Diabetic Kidney Disease: Emerging Therapeutic Perspectives
International Journal of Molecular Sciences
March 2026
Yanai H.
Open Access
A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases
Antioxidants
August 2024
Jin S.
Open Access
Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models
International Journal of Molecular Sciences
August 2024
Varda L.
Open Access
Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors
International Journal of Molecular Sciences
February 2023
Badran M.
Open Access
In Silico Analysis of Antioxidant Phytochemicals with Potential NADPH Oxidase Inhibitory Effect
Journal of Health Science and Medical Research
2023
Mhya D.H.
Open Access
Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
Kidney International Supplements
April 2022
Nakamura T.
Open Access
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
Kidney International Supplements
April 2022
Hollenberg M.D.
Open Access
Therapeutic potential of spironolactone in ankylosing spondylitis patients: Relation to disease activity and functional status
Egyptian Rheumatologist
April 2021
Verma I.
Open Access
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Frontiers in Cardiovascular Medicine
2021
Lin X.
Open Access
SRC-3 Knockout Attenuates Myocardial Injury Induced by Chronic Intermittent Hypoxia in Mice
Oxidative Medicine and Cellular Longevity
2021
Wang W.
Open Access
COVID-19—the potential beneficial therapeutic effects of spironolactone during SARS-CoV-2 infection
Pharmaceuticals
January 2021
Kotfis K.
Open Access
Research progress of the effect of cell-specific mineralocorticoid receptor on blood pressure regulation
Medical Journal of Chinese People S Liberation Army
28 October 2020
Qian-Yu M.
Impact of mineralocorticoid receptor antagonist in renal transplant patients: a systematic review and meta-analysis of randomized controlled trials
Journal of Nephrology
1 June 2020
Abdelhakim A.M.
Vascular and inflammatory mineralocorticoid receptors in kidney disease
Acta Physiologica
1 February 2020
Barrera-Chimal J.
Vascular mineralocorticoid receptor activation and disease
Experimental Eye Research
November 2019
Barrera-Chimal J.
Open Access
Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model
BMC Nephrology
6 September 2019
Wang C.C.
Open Access
Spironolactone reduces oxidative stress in living donor kidney transplantation: A randomized controlled trial
American Journal of Physiology Renal Physiology
September 2019
Morales-Buenrostro L.E.
Open Access
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Kidney International
August 2019
Barrera-Chimal J.
Open Access
Cellular death, reactive oxygen species (ROS) and diabetic complications review-Article
Cell Death and Disease
1 February 2018
Volpe C.M.O.
Open Access
Spironolactone protects against diabetic cardiomyopathy in streptozotocin-induced diabetic rats
Journal of Diabetes Research
2018
Liu W.
Open Access
Therapeutic effects of spironolactone on a collagen-induced arthritis model of rheumatoid arthritis
Egyptian Rheumatologist
1 April 2017
Verma I.
Open Access
Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults
Experimental Gerontology
January 01, 2016
Hwang M.H.
All Open Access, Green